OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2020 Financial Results on March 10, 2021
OrthoPediatrics Corp. (NASDAQ: KIDS) will release its Q4 and full-year 2020 financial results on March 10, 2021, after market close. The company is ensuring accurate accounting for complex transactions, including the acquisition of ApiFix and the transition to sales agencies in three European markets. A conference call will follow on March 11, 2021, at 8:00 a.m. ET to discuss these results. OrthoPediatrics specializes in pediatric orthopedics and markets 35 surgical systems in the U.S. and 43 other countries.
- Comprehensive product offering with 35 surgical systems targeting pediatric orthopedic market
- Focus on expanding presence in European markets through sales agencies
- Delays in financial reporting due to complex accounting for acquisitions and market transitions
Conference Call to Discuss Results on March 11, 2021 at 8:00 a.m. ET
WARSAW, Ind., March 03, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company is scheduled to release its fourth quarter and full year 2020 financial results on Wednesday, March 10, 2021, after the market closes. The Company is taking the necessary time to ensure the accurate accounting treatment of complex transactions, including the acquisition of ApiFix and the recent conversion of three European markets to sales agencies.
OrthoPediatrics will host a conference call on Thursday, March 11, 2021, at 8:00 a.m. ET to discuss the results. The dial-in numbers are (855) 289-4603 for domestic callers and (614) 999-9389 for international callers. The conference ID number is 9362699. A live webcast of the conference call will be available online from the investor relations page of the OrthoPediatrics’ corporate website at www.orthopediatrics.com.
A replay of the webcast will remain available on OrthoPediatrics’ website, www.orthopediatrics.com, until the Company releases its first quarter 2021 financial results. In addition, a telephonic replay of the call will be available until March 18, 2021. The replay dial-in numbers are (855) 859-2056 for domestic callers and (404) 537-3406 for international callers. Please use the replay conference ID number 9362699.
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 35 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and 43 countries outside the United States. For more information, please visit www.orthopediatrics.com.
Investor Contact
The Ruth Group
Christine Petraglia / James Salierno
cpetraglia@theruthgroup / jsalierno@theruthgroup.com
917.633.8980 / 973-255-8361
FAQ
When will OrthoPediatrics announce its Q4 2020 financial results?
What is the date of the OrthoPediatrics conference call?
What stock symbol does OrthoPediatrics operate under?
What are the recent acquisitions by OrthoPediatrics?
How many countries does OrthoPediatrics distribute its products?
